Filana Therapeutics, Inc. (FLNA) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts FLNA Hot Sheet
Join SI Premium – FREE
Filana Therapeutics, Inc. (NASDAQ: FLNA) reported Q2 EPS of ($0.18), $0.03 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Filana Therapeutics, Inc. (FLNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Costco (COST) Tops Q4 EPS by 20c
- Northrop Grumman wins three U.S. defense contracts worth $308M
- Ancora pressures H.B. Fuller board to explore strategic alternatives
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
